[The challenge of antitrombotic treatment prescription in older adults with atrial fibrillation. Does age justify the anti-thrombotic strategy in elderly patients with atrial fibrillation?]

Rev Esp Geriatr Gerontol. 2018 Nov-Dec;53(6):317-318. doi: 10.1016/j.regg.2018.05.005. Epub 2018 Jul 4.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation / complications*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Hemorrhage / chemically induced
  • Humans
  • Risk Factors
  • Stroke / etiology*
  • Stroke / prevention & control*

Substances

  • Fibrinolytic Agents